About the McGill Center for Translational Research in Cancer (MCTRC)
The MCTRC is the translational research arm of the Segal Cancer Centre and Lady Davis Research Institute at the Jewish General Hospital. The MCTRC houses clinician scientists, and fundamental researchers who conduct research in various areas of healthcare interest. The focus is on innovation, new knowledge generation and rapid translation of discoveries from the lab to the clinic. The main objective of its members is to translate fundamental laboratory and clinical research data into clinical outcomes of benefit for the diagnosis, treatment and prevention of cancer.


About MEDTEQ+
MEDTEQ+ is the pan-Canadian Consortium for Industrial Research and Innovation in Medical Technology. Its mission is to accelerate the development of innovative technological solutions to improve patients’ health and quality of life. MEDTEQ+ supports their validation and integration in the healthcare system and their impact, both locally and globally, by bringing together the complementary skills of industrial and academic partners, and with those of healthcare providers. MEDTEQ+ receives financial support of the Government of Quebec, the Government of Canada (delivered through the Centres of Excellence for Commercialization and Research (CECR)), the private sector and complementary partners to foster research-industry relations.


About the TransMedTech Institute
The TransMedTech Institute (iTMT) aims to support innovation in medical technologies to meet the needs of end-users and the healthcare sector, in order to facilitate and accelerate their development and implementation in the healthcare system. Under the leadership of Polytechnique Montréal and four other founding institutions (Université de Montréal, CHU Sainte-Justine, CHUM and the Jewish General Hospital), the iTMT brings together more than fifty partner institutions, together maintaining a first-rate scientific infrastructure to support the development and validation of medical technologies. The TransMedTech Institute is supported by the Canada First Research Excellence Fund, the Ministère de l'Économie, de l'Innovation et de l’Énergie du Québec and the Fonds de recherche du Québec, as well as several other philanthropic, government, socio-economic and industrial university partners.

Back to HCB News

Rad Oncology Homepage